Cerity Partners LLC: EPS position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Cerity Partners LLC on EPS, newest first. How the timeline and the estimate are built.
Cerity Partners LLC held 4,163 EPS shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 4,163 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $323,840.
13F-HR 0001172661-26-003640 filed by Cerity Partners LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 4,163 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $283,542.
13F-HR 0001172661-26-002233 filed by Cerity Partners LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 4,163 sharesChange vs previous 13F -482 shares
<0.01% of the 13F portfolio, value $294,991.
13F-HR 0001172661-26-000617 filed by Cerity Partners LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 4,645 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $320,227.
13F-HR 0001566475-25-000018 filed by Cerity Partners LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 4,645 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $297,327.
13F-HR 0001566475-25-000013 filed by Cerity Partners LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 4,645 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $275,356.
13F-HR 0001566475-25-000008 filed by Cerity Partners LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).